United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
367.84
+3.51 (0.96%)
Nov 21, 2024, 2:21 PM EST - Market open

United Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for United Therapeutics stock have an average target of 370.86, with a low estimate of 280 and a high estimate of 600. The average target predicts an increase of 0.82% from the current stock price of 367.84.

Analyst Consensus: Buy
Target Low Average Median High
Price $280 $370.86 $370 $600
Change -23.88% +0.82% +0.59% +63.11%

Analyst Ratings

The average analyst rating for UTHR stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 243466
Buy 766665
Hold 122222
Sell 001111
Strong Sell 000000
Total 101212131514

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Goldman Sachs
Goldman Sachs
Hold
Maintains
$243$302
Hold Maintains $243$302 -17.90% Nov 1, 2024
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Maintains
$319$344
Strong Buy Maintains $319$344 -6.48% Oct 31, 2024
Oppenheimer
Oppenheimer
Buy
Maintains
$575$600
Buy Maintains $575$600 +63.11% Oct 31, 2024
Argus Research
Argus Research
Strong Buy
Maintains
$360$400
Strong Buy Maintains $360$400 +8.74% Oct 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$400$425
Strong Buy Maintains $400$425 +15.54% Oct 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.94B
from 2.33B
Increased by 26.32%
Revenue Next Year
3.25B
from 2.94B
Increased by 10.37%
EPS This Year
24.99
from 19.81
Increased by 26.16%
EPS Next Year
28.44
from 24.99
Increased by 13.78%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
1.45B1.48B1.69B1.94B2.33B2.94B3.25B3.45B
Revenue Growth
-11.00%2.38%13.63%14.88%20.20%26.32%10.37%6.41%
EPS
-2.3911.5410.0615.0019.8124.9928.4428.49
EPS Growth
---12.82%49.11%32.07%26.16%13.78%0.20%
Forward PE
-----14.7212.9412.91
No. Analysts -----181814
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 3.1B 3.5B 3.8B
Avg 2.9B 3.2B 3.5B
Low 2.8B 2.8B 2.9B

Revenue Growth

Revenue Growth 20242025202620272028
High
32.6%
20.5%
17.6%
Avg
26.3%
10.4%
6.4%
Low
19.1%
-5.0%
-11.8%

EPS Forecast

EPS 20242025202620272028
High 27.26 36.42 33.86
Avg 24.99 28.44 28.49
Low 21.56 22.34 16.65

EPS Growth

EPS Growth 20242025202620272028
High
37.6%
45.7%
19.1%
Avg
26.2%
13.8%
0.2%
Low
8.8%
-10.6%
-41.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.